Greenway Greenhouse Cannabis Corporation

C$0.08As of Sun 8 Nov 2026, 12:00 UTC
CSE:GWAYHealthcare
Country Canada
PE (Fwd) •••
TSR 5Y CAGR (30.16%)
Div yield —
ROE (35.79%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.55
PE TTM —
TSR TTM (52.94%)
Mkt cap C$10.73M
ROIC (4.98%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.0851
6.32%
(43.12%)
Hold 1|10|6|3|5
3Q26
4Q26
1Q27
2Q27
Earnings per share$
—
—
—
—
4.26%
4.00%
8.46%
5.53%
Revenue$M
0.476
0.483
0.502
0.491
2.29%
2.08%
1.30%
0.55%
Peers (US$7.592M)
Cap (US$)
PE
8.604M
—
7.464M
68.07x
Capital
TTM
5Y
10Y
Leveragex
0.463
0.061
0.050
EBIT/Intx
1.540
0.492
0.384
Own earn%
10.87
116.62
79.83
Sh yield%
28.25
40.32
40.15
Owners
Insiders/Inst%
1.26
36.17
Short interest%
2.46
SBC / revenue%
5.12
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
3
Op margin range%
27–33
$1 testx
—
Incr. ROIC%
10